Crossmark

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice

Crossref DOI link: https://doi.org/10.1186/s12933-019-0820-6

Published Online: 2019-02-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Adingupu, Damilola D. http://orcid.org/0000-0002-0312-2359
Göpel, Sven O.

Grönros, Julia

Behrendt, Margareta

Sotak, Matus

Miliotis, Tasso

Dahlqvist, Ulrika

Gan, Li-Ming

Jönsson-Rylander, Ann-Cathrine
License Information

Text and Data Mining valid from 2019-02-07
More Information

Article History

Received: 4 October 2018

Accepted: 28 January 2019

First Online: 7 February 2019